[go: up one dir, main page]

CA2661662A1 - Methodes de selection d'agents qui inhibent la liaison entre mphosph1 et prc1 - Google Patents

Methodes de selection d'agents qui inhibent la liaison entre mphosph1 et prc1 Download PDF

Info

Publication number
CA2661662A1
CA2661662A1 CA002661662A CA2661662A CA2661662A1 CA 2661662 A1 CA2661662 A1 CA 2661662A1 CA 002661662 A CA002661662 A CA 002661662A CA 2661662 A CA2661662 A CA 2661662A CA 2661662 A1 CA2661662 A1 CA 2661662A1
Authority
CA
Canada
Prior art keywords
polypeptide
seq
mphosphi
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002661662A
Other languages
English (en)
Inventor
Yusuke Nakamura
Toyomasa Katagiri
Shuichi Nakatsuru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2661662A1 publication Critical patent/CA2661662A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G01N33/57557—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002661662A 2006-08-25 2007-08-23 Methodes de selection d'agents qui inhibent la liaison entre mphosph1 et prc1 Abandoned CA2661662A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84012406P 2006-08-25 2006-08-25
US60/840,124 2006-08-25
PCT/JP2007/066827 WO2008023842A1 (fr) 2006-08-25 2007-08-23 Méthodes de sélection d'agents qui inhibent la liaison entre mphosph1 et prc1

Publications (1)

Publication Number Publication Date
CA2661662A1 true CA2661662A1 (fr) 2008-02-28

Family

ID=38824945

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002661662A Abandoned CA2661662A1 (fr) 2006-08-25 2007-08-23 Methodes de selection d'agents qui inhibent la liaison entre mphosph1 et prc1

Country Status (5)

Country Link
EP (1) EP2059812A1 (fr)
JP (1) JP2010501827A (fr)
CN (1) CN101558307A (fr)
CA (1) CA2661662A1 (fr)
WO (1) WO2008023842A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014001363B1 (pt) 2011-08-12 2021-06-01 Oncotherapy Science, Inc. Composições para indução de um linfócito t citotóxico (ctl), para indução de uma célula apresentadora de antígeno (apc) tendo capacidade de indução de ctl, composição farmacêutica, métodos in vitro para indução de apc e de ctl, usos de peptídeos e vetor
BR112018006894A2 (pt) 2015-10-08 2018-10-16 Oncotherapy Science, Inc. peptídeo derivado de mphosph1 e vacina que inclui o mesmo
JP2021527064A (ja) * 2018-06-07 2021-10-11 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Ｐｒｃ１阻害剤及びそれを用いた治療方法
CN119530291B (zh) * 2025-01-14 2025-06-27 青岛农业大学 PsCLF基因在调控牡丹花芽内休眠和生长中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078205A1 (fr) * 2003-03-03 2004-09-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Ciblage d'une proteine prc1 pour le traitement du cancer du pancreas
EP2311983A1 (fr) * 2005-02-10 2011-04-20 Oncotherapy Science, Inc. Procédé de traitment de cancer de la vessie en utilisant d'ARNsi

Also Published As

Publication number Publication date
CN101558307A (zh) 2009-10-14
JP2010501827A (ja) 2010-01-21
WO2008023842A1 (fr) 2008-02-28
EP2059812A1 (fr) 2009-05-20

Similar Documents

Publication Publication Date Title
CN101835894A (zh) Ebi3、dlx5、nptx1和cdkn3用作肺癌治疗和诊断的靶基因
US20110263012A1 (en) Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex
KR20090064378A (ko) 유방암 관련 유전자 및 폴리펩티드
JP2010501172A (ja) 肺癌に対する予後マーカーおよび治療標的
JP5272134B2 (ja) Ｓｍｙｄ３によるｖｅｇｆｒ１のメチル化調整因子を同定する方法
EP1787122B1 (fr) GENE RELATIF AU CANCER DU POUMON NON A PETITES CELLULES, ANLN, ET SES INTERACTIONS AVEC LE RhoA
US20100184047A1 (en) Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex
JP2009536516A (ja) 肺癌の治療標的としてのＮＭＵ−ＧＨＳＲ１ｂ／ＮＴＳＲ１発癌シグナル伝達経路
WO2008023841A1 (fr) Gène associé au cancer du sein, melk, et ses interactions avec bcl-g
CA2661662A1 (fr) Methodes de selection d'agents qui inhibent la liaison entre mphosph1 et prc1
EP2785870B1 (fr) Smyd2 en tant que gène cible pour une thérapie anticancéreuse et le diagnostic du cancer
CN101528768A (zh) 与乳腺癌相关的基因和多肽
KR20110067107A (ko) 종양 마커 및 암에 대한 치료적 표적으로서 ｔｂｃ１ｄ７
JP2011518541A (ja) 癌治療法および癌診断のための標的遺伝子としてのＣ２ｏｒｆ１８
WO2008020653A1 (fr) Utilisation de la protéine reconnaissant la jonction de holliday et associée au cancer
WO2010023854A1 (fr) Gène lgn/gpsm2 associé au cancer

Legal Events

Date Code Title Description
FZDE Discontinued